SUCAMPO PHARMACEUTICALS INC's ticker is and the CUSIP is 864909AA4. A total of 23 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $2,732,000 | +32.2% | 2,250,000 | +12.5% | 0.02% | +33.3% |
Q3 2017 | $2,066,000 | +5.8% | 2,000,000 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $1,953,000 | -1.3% | 2,000,000 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $1,979,000 | -7.1% | 2,000,000 | 0.0% | 0.01% | -7.7% |
Q4 2016 | $2,130,000 | – | 2,000,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Southpaw Asset Management LP | 19,125,000 | $18,683,000 | 20.40% |
Mohican Financial Management, LLC | 1,500,000 | $1,464,000 | 2.55% |
Wellesley Asset Management | 41,221 | $40,448,000 | 2.09% |
Context Capital Management, LLC | 2,000,000 | $1,961,000 | 1.40% |
LINDEN ADVISORS LP | 30,205,000 | $29,574,000 | 1.25% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,341,000 | $30,675,000 | 0.46% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 27,000,000 | $26,388,000,000 | 0.43% |
AQR Arbitrage LLC | 34,950,000 | $34,295,000 | 0.38% |
WOLVERINE ASSET MANAGEMENT LLC | 25,196,000 | $24,617,000 | 0.31% |
ADVENT CAPITAL MANAGEMENT /DE/ | 4,308,000 | $4,220,000 | 0.08% |